Zoetis, Inc. (ZTS)
79.38
+0.96
(+1.22%)
USD |
NYSE |
Oct 16, 16:00
79.53
+0.15
(+0.19%)
After-Hours: 20:00
Zoetis Free Cash Flow (Quarterly) : 538.00M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 538.00M |
| March 31, 2026 | 291.00M |
| December 31, 2025 | 732.00M |
| September 30, 2025 | 805.00M |
| June 30, 2025 | 459.00M |
| March 31, 2025 | 337.00M |
| December 31, 2024 | 689.00M |
| September 30, 2024 | 784.00M |
| June 30, 2024 | 370.00M |
| March 31, 2024 | 455.00M |
| December 31, 2023 | 699.00M |
| September 30, 2023 | 579.00M |
| June 30, 2023 | 17.00M |
| March 31, 2023 | 326.00M |
| December 31, 2022 | 570.00M |
| September 30, 2022 | 372.00M |
| June 30, 2022 | 190.00M |
| March 31, 2022 | 194.00M |
| December 31, 2021 | 511.00M |
| September 30, 2021 | 534.00M |
| June 30, 2021 | 368.00M |
| March 31, 2021 | 323.00M |
| December 31, 2020 | 566.00M |
| September 30, 2020 | 445.00M |
| June 30, 2020 | 348.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 314.00M |
| December 31, 2019 | 416.00M |
| September 30, 2019 | 378.00M |
| June 30, 2019 | 215.00M |
| March 31, 2019 | 326.00M |
| December 31, 2018 | 446.00M |
| September 30, 2018 | 476.00M |
| June 30, 2018 | 194.00M |
| March 31, 2018 | 336.00M |
| December 31, 2017 | 525.00M |
| September 30, 2017 | 391.00M |
| June 30, 2017 | 129.00M |
| March 31, 2017 | 77.00M |
| December 31, 2016 | 226.00M |
| September 30, 2016 | 182.00M |
| June 30, 2016 | 83.00M |
| March 31, 2016 | 6.00M |
| December 31, 2015 | 197.00M |
| September 30, 2015 | 152.00M |
| June 30, 2015 | 76.00M |
| March 31, 2015 | 15.00M |
| December 31, 2014 | 336.00M |
| September 30, 2014 | 61.00M |
| June 30, 2014 | 102.00M |
| March 31, 2014 | -68.00M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Eli Lilly & Co. | 4.475B |
| Merck & Co., Inc. | 4.477B |
| Pfizer Inc. | 302.00M |
| Phibro Animal Health Corp. | 5.225M |
| Bristol Myers Squibb Co. | 3.088B |